Table 3.
|
HIReA |
FKGL |
||||
---|---|---|---|---|---|---|
Section name | Average | Median | Q1, Q3 | Average | Median | Q1, Q3 |
Patient leaflet | ||||||
Related termsa | −0.8863 | −0.9375 | −0.98, −0.85 | 28.9894 | 28.2567 | 23.48, 33.68 |
Synonyms | −0.5846 | −0.5800 | −0.77, −0.45 | 14.7009 | 14.6260 | 13.61, 15.38 |
Scientific evidenceb | 0.0629 | 0.0175 | −0.03, 0.08 | 13.0968 | 12.8017 | 12.68, 13.80 |
Tradition/theory | −0.5075 | −0.5325 | −0.68, −0.41 | 24.1679 | 21.7670 | 20.15, 29.72 |
Dosing | −0.3983 | −0.3575 | −0.64, −0.19 | 12.4706 | 12.6503 | 11.87, 13.02 |
Safety | −0.3246 | −0.2875 | −0.45, −0.20 | 13.3046 | 13.2601 | 12.77, 14.01 |
Interactions | −0.2458 | −0.2475 | −0.43, −0.07 | 13.5564 | 13.1288 | 12.38, 14.41 |
Professional leaflet | ||||||
Synonymsa | −0.9488 | −0.9525 | −0.97, −0.94 | 29.4332 | 30.0594 | 24.98, 31.09 |
Effectiveness | −0.8763 | −0.9075 | −0.94, −0.86 | 18.4383 | 17.6172 | 17.11, 18.56 |
Dosing/toxicology | −0.5242 | −0.4350 | −0.88, −0.27 | 13.6618 | 14.1258 | 12.36, 14.68 |
Precautions | −0.6879 | −0.6950 | −0.82, −0.58 | 14.4580 | 14.8468 | 13.91, 15.07 |
Interactions | −0.6925 | −0.6800 | −0.85, −0.52 | 16.0690 | 16.2432 | 14.69, 17.15 |
Mechanism of action | −0.9296 | −0.9525 | −0.98, −0.92 | 16.6438 | 16.7223 | 15.15, 18.06 |
Historyb | −0.4446 | −0.3850 | −0.57, −0.24 | 12.9608 | 12.6659 | 12.09, 13.80 |
Evidence discussion | −0.8013 | −0.8725 | −0.93, −0.73 | 14.5151 | 14.5379 | 14.00, 15.04 |
Products studied | −0.5604 | −0.5800 | −0.93, −0.38 | 13.6061 | 12.9109 | 10.90, 15.69 |
NS, Natural Standard; HIReA, health information readability analyzer; FKGL, Flesch-Kincaid Grade Level; Q1, first quartile; Q3, third quartile.
Indicates hardest section.
Indicates least difficult section; evaluated 12 documents each for professional leaflets and patient leaflets.